Flashpoint Therapeutics Celebrates Founder Professor Chad A. Mirkin’s Selection for the 2027 ACS Priestley Medal Flashpoint Therapeutics, a biotechnology company focused on advancing next-generation nanomedicines, has announced that its founder, Professor Chad A. Mirkin, has been named the recipient of…
Immunomic Therapeutics Doses First Patient in Phase 1 Trial of ITI-5000 Therapeutic Cancer Vaccine for Triple-Negative Breast Cancer Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company and U.S.-based subsidiary of HLB, has announced an important milestone in the development of…
Bayer and Henry Ford Health Form Strategic Partnership to Expand Patient Access to Clinical Trials and Accelerate Medical Innovation Bayer, a global life sciences company with a broad portfolio spanning pharmaceuticals, consumer health, and crop science, has announced a strategic…
Takeda Reports New Phase 3 Data Showing Zasocitinib Delivers Strong Skin Clearance Across Difficult-to-Treat Areas in Plaque Psoriasis Takeda has announced new findings from its two pivotal Phase 3 clinical studies evaluating zasocitinib (TAK-279), a next-generation oral tyrosine kinase 2…
Cutera and Restimulate Health Partner to Advance Technology-Driven Rehabilitation with truFlex Integration CUTERA, INC., a global provider of aesthetic and dermatologic technologies, has announced a strategic partnership with Restimulate Health, a healthcare company focused on enhancing rehabilitation outcomes through clinically…
Anova Enterprises and Nouveau Biosciences Partner to Advance Clinical Development of Kromastat for Hard-to-Treat Cancers Anova Enterprises, Inc., a technology-enabled contract research organization (CRO) dedicated to accelerating the development of innovative therapies, has announced a strategic partnership with Nouveau Biosciences,…
Infusion for Health Expands Home Infusion Services to Enhance Patient Access and Flexible Specialty Care Infusion for Health, a leading provider of specialty infusion therapy services, has announced the continued expansion of its Home Infusion division, reinforcing its commitment to…
Revel Pharmaceuticals Publishes Nature Communications Study Demonstrating Enzyme That Reverses Age-Related Protein Damage Revel Pharmaceuticals has announced the publication of new research in Nature Communications describing a breakthrough enzyme capable of reversing a long-recognized form of age-related protein damage. The…
Charles River Laboratories Partners with Arovella Therapeutics to Advance GMP Next-Generation Sequencing for CAR-iNKT Cell Therapy Development Charles River Laboratories International, Inc. has announced a strategic collaboration with Arovella Therapeutics Ltd. to provide Good Manufacturing Practice (GMP)-compliant Next Generation Sequencing…
Cognito Therapeutics Presents New Biomarker Findings Highlighting Potential Mechanism of Spectris™ Neuromodulation for Alzheimer’s Disease Cognito Therapeutics, a clinical-stage neurotechnology company focused on developing innovative therapies for neurodegenerative diseases, has unveiled new exploratory biomarker findings that provide additional insight into…
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd, and Polpharma Biologics International AG announced a global licensing agreement granting Teva…
Bifrost Biosystems Signs Commercial Supply Agreement with Illumina to Accelerate Optical Pooled Screening Platform Launch Bifrost Biosystems has announced a significant commercial milestone with the signing of a supply agreement with Illumina that will enable the integration of Illumina’s widely…